Special Seminar Series
“Using Stem Cells and Reprogramming to Understand Neural Degeneration”
Kevin Eggan, Ph.D.,
Assistant professor, Department of Stem Cell and Regenerative Biology, and Principal Investigator, Harvard Stem Cell Institute, Harvard University; Assistant Investigator, Stowers Medical Institute
Wednesday, May 27, 2009
4:00 p.m.-5:00 p.m. (Refreshments, 3:45 p.m.)
Second Floor, Welch Hall
Di Giorgio, F. P., G. L. Boulting, S. Bobrowicz, and K. C. Eggan. 2008. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell. 3(6):637-648.
Di Giorgio, F. P., M. A. Carrasco, M. C. Siao, T. Maniatis, and K. Eggan. 2007. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nature Neuroscience. 10(5):608-614.
Dimos, J. T., K. T. Rodolfa, K. K. Niakan, L. M. Weisenthal, H. Mitsumoto, W. Chung, G. F. Croft, et al. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 321(5893):1218-1221.
Eggan, K. 2008. Using stem cells and reprogramming to understand disease. Regenerative Medicine. 3(6):799-801.
Egli, D., G. Birkhoff, and K. Eggan. 2008. Mediators of reprogramming: Transcription factors and transitions through mitosis. Nature Reviews Molecular Cell Biology. 9(7):505-516.
Okarma, T., and K. Eggan. 2008. A seismic shift for stem cell research. Science. 319(5863):560-561+563.